Literature DB >> 14573334

Association between microalbuminuria and the metabolic syndrome: NHANES III.

Latha Palaniappan1, Mercedes Carnethon, Stephen P Fortmann.   

Abstract

We investigated whether microalbuminuria was associated with the metabolic syndrome by comparing the strength of the association between microalbuminuria and the syndrome as a whole and its individual components. This investigation included 5659 women and men aged 20 to 80 years from the cross-sectional, nationally representative, Third National Health and Nutrition Examination Survey (NHANES III: 1988-1994). Metabolic syndrome was defined as any three of the following: increased waist circumference, increased triglycerides, decreased HDL cholesterol, increased blood pressure, or high fasting glucose. Microalbuminuria was defined as urinary albumin/creatinine ratio of 30 to 300 mg/g. Microalbuminuria was present in 7.8% of women and 5.0% of men. Log linear analysis revealed a significant association between the metabolic syndrome and microalbuminuria in both genders (women chi(2) = 44.1; men chi(2) = 59.6; P <.0001 for both). Microalbuminuria was more common in both women (odds ratio [OR] = 2.2; 95% confidence interval [CI] 1.44, 3.34) and men (OR = 4.1; 95% CI 2.45, 6.74) with metabolic syndrome compared to those without it; 34% of women and 42% of men with microalbuminuria also had metabolic syndrome. After adjusting for other components of the metabolic syndrome, hypertension demonstrated the strongest association with microalbuminuria in both women (OR = 3.34; 95% CI 2.45, 4.55) and men (OR = 2.51; 95% CI 1.63, 3.86). Microalbuminuria and metabolic syndrome are associated in a large, nationally representative cohort, possibly due to early renal effects of hypertension, and it may be useful to consider microalbuminuria as a component of the metabolic syndrome.

Entities:  

Mesh:

Year:  2003        PMID: 14573334     DOI: 10.1016/s0895-7061(03)01009-4

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  70 in total

1.  Albuminuria and racial disparities in the risk for ESRD.

Authors:  William M McClellan; David G Warnock; Suzanne Judd; Paul Muntner; Reshma Kewalramani; Mary Cushman; Leslie A McClure; Britt B Newsome; George Howard
Journal:  J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 10.121

2.  Prevalence of nonrefractive visual impairment in US adults and associated risk factors, 1999-2002 and 2005-2008.

Authors:  Fang Ko; Susan Vitale; Chiu-Fang Chou; Mary Frances Cotch; Jinan Saaddine; David S Friedman
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272

Review 3.  Obesity in kidney disease: A heavyweight opponent.

Authors:  Raphael Jose Ferreira Felizardo; Marina Burgos da Silva; Cristhiane Favero Aguiar; Niels Olsen Saraiva Câmara
Journal:  World J Nephrol       Date:  2014-08-06

4.  Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome.

Authors:  G Grassi; R Dell'Oro; F Quarti-Trevano; F Scopelliti; G Seravalle; F Paleari; P L Gamba; G Mancia
Journal:  Diabetologia       Date:  2005-06-03       Impact factor: 10.122

5.  Association of polycystic ovary syndrome and a non-dipping blood pressure pattern in young women.

Authors:  Ayse Kargili; Feridun Karakurt; Benan Kasapoglu; Aysel Derbent; Cemile Koca; Yusuf Selcoki
Journal:  Clinics (Sao Paulo)       Date:  2010-05       Impact factor: 2.365

6.  Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease.

Authors:  Kosaku Nitta
Journal:  Cardiol Res Pract       Date:  2010-10-07       Impact factor: 1.866

7.  Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents.

Authors:  Stephanie Nguyen; Charles McCulloch; Paul Brakeman; Anthony Portale; Chi-yuan Hsu
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

Review 8.  Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.

Authors:  Gregory J Weber; Sathnur Pushpakumar; Suresh C Tyagi; Utpal Sen
Journal:  Pharmacol Res       Date:  2016-09-04       Impact factor: 7.658

Review 9.  Insulin and its role in chronic kidney disease.

Authors:  Robert H Mak
Journal:  Pediatr Nephrol       Date:  2007-10-11       Impact factor: 3.714

10.  Albumin excretion rate in normal adolescents: relation to insulin resistance and cardiovascular risk factors and comparisons to type 1 diabetes mellitus patients.

Authors:  Erin Rademacher; Michael Mauer; David R Jacobs; Blanche Chavers; Julia Steinke; Alan Sinaiko
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.